1. Home
  2. CTKB vs ORC Comparison

CTKB vs ORC Comparison

Compare CTKB & ORC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTKB
  • ORC
  • Stock Information
  • Founded
  • CTKB 1990
  • ORC 2010
  • Country
  • CTKB United States
  • ORC United States
  • Employees
  • CTKB N/A
  • ORC N/A
  • Industry
  • CTKB Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • ORC Real Estate Investment Trusts
  • Sector
  • CTKB Health Care
  • ORC Real Estate
  • Exchange
  • CTKB Nasdaq
  • ORC Nasdaq
  • Market Cap
  • CTKB 718.8M
  • ORC 660.1M
  • IPO Year
  • CTKB 2021
  • ORC 2013
  • Fundamental
  • Price
  • CTKB $3.65
  • ORC $6.55
  • Analyst Decision
  • CTKB Buy
  • ORC Buy
  • Analyst Count
  • CTKB 2
  • ORC 3
  • Target Price
  • CTKB $7.00
  • ORC $9.50
  • AVG Volume (30 Days)
  • CTKB 908.8K
  • ORC 4.9M
  • Earning Date
  • CTKB 05-07-2025
  • ORC 04-24-2025
  • Dividend Yield
  • CTKB N/A
  • ORC 22.02%
  • EPS Growth
  • CTKB N/A
  • ORC N/A
  • EPS
  • CTKB N/A
  • ORC 0.58
  • Revenue
  • CTKB $200,453,000.00
  • ORC $54,406,000.00
  • Revenue This Year
  • CTKB $4.87
  • ORC N/A
  • Revenue Next Year
  • CTKB $8.74
  • ORC $51.24
  • P/E Ratio
  • CTKB N/A
  • ORC $11.38
  • Revenue Growth
  • CTKB 3.85
  • ORC N/A
  • 52 Week Low
  • CTKB $3.27
  • ORC $5.69
  • 52 Week High
  • CTKB $7.63
  • ORC $9.01
  • Technical
  • Relative Strength Index (RSI)
  • CTKB 38.95
  • ORC 35.29
  • Support Level
  • CTKB $3.27
  • ORC $5.85
  • Resistance Level
  • CTKB $3.80
  • ORC $6.46
  • Average True Range (ATR)
  • CTKB 0.25
  • ORC 0.34
  • MACD
  • CTKB 0.03
  • ORC -0.02
  • Stochastic Oscillator
  • CTKB 45.78
  • ORC 45.26

About CTKB Cytek Biosciences Inc.

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.

About ORC Orchid Island Capital Inc.

Orchid Island Capital Inc is a specialty finance company that invests in residential mortgage-backed securities. The principal and interest payments of its RMBS are guaranteed by the Federal National Mortgage Association, the Federal Home Loan Mortgage Corporation, or the Government National Mortgage Association, and are backed by single-family residential mortgage loans. The company's investment portfolio is divided into two categories namely traditional pass-through Agency RMBS; and structured Agency RMBS, such as collateralized mortgage obligations, interest-only securities, inverse interest-only securities, and principal-only securities, among other types of structured Agency RMBS.

Share on Social Networks: